NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

UCLA has allowed NWBO to commercialize its technology and its interest in the technology improvements and is one of the original patent holders. The head of the relevant department at UCLA, Dr. Liau, is the lead investigator of the trial and is credited as an inventor, along with Dr. Prins. NWBO is effectively commercializing technology developed / co-developed with the company in collaboration through the trials and other efforts that NWBO has financed. But UCLA is an original patent holder and therefore retains a substantial interest in the success of the technology.

Of course, UCLA has an interest here. That you could even post such nonsense again is a testament to the fact that evidence and facts don't matter on bulletin boards.

That is the most ridiculous post you've made all day.